RNS Number : 9446H Renalytix PLC 11 October 2024 Renalytix plc (" Renalytix " or the " Company ") Posting of Circular and Notice of General Meeting LONDON and NEW YORK , 11 October, 2024 ̶ Renalytix plc (LSE: RENX) (OTCQB: RNLXY), an artificial intelligence-enabled in vitro diagnostics
RNS Number : 7887H Renalytix PLC 11 October 2024 Renalytix plc ("Renalytix" or the "Company") Director/PDMR Dealing LONDON and NEW YORK , 11 October 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing
RNS Number : 7886H Renalytix PLC 11 October 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYWL4Y04 Issuer Name RENALYTIX PLC UK or Non- UK Issuer UK 2. Reason for Notification An event changing the breakdown of voting rights 3.
RNS Number : 7884H Renalytix PLC 11 October 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYWL4Y04 Issuer Name RENALYTIX PLC UK or Non- UK Issuer UK 2. Reason for Notification An event changing the breakdown of voting rights 3.
RNS Number : 5976H Renalytix PLC 09 October 2024 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing
RNS Number : 4004H Renalytix PLC 08 October 2024 Renalytix plc (" Renalytix " or the " Company ") Admission of Shares & Total Voting Rights Renalytix (AIM: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to
RNS Number : 3346H Renalytix PLC 08 October 2024 Renalytix plc ("Renalytix" or the "Company") Commencement of trading on OTCQB in the United States Renalytix plc American Depository Shares (ADSs) begin trading on OTCQB Venture Market under symbol "RNLXY" effective from Market Open on
RNS Number : 4887G Renalytix PLC 01 October 2024 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN (TOGETHER THIS "ANNOUNCEMENT") IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE
RNS Number : 4130G Renalytix PLC 01 October 2024 Renalytix plc ("Renalytix" or the "Company") Audited US GAAP financial results for the fiscal year ended 30 June 2024 LONDON and NEW YORK , 1 October, 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in
RNS Number : 3313G Renalytix PLC 30 September 2024 THIS ANNOUNCEMENT, INCLUDING THE APPENDICES TO THIS ANNOUNCEMENT, AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ,
